Indivior | 营业费用



Operating Expenses 更改 日
AstraZeneca USD 12.86B 2.06B 2024-12
Eli Lilly USD 8.38B 1.53B 2024-12
Glaxosmithkline GBP 7.42B 408M 2024-12
Halozyme Therapeutics USD 122.51M 4.38M 2024-12
Indivior 7M 296M 2024-12
J&J USD 8.26B 10.37B 2025-03
Kyowa Hakko Kirin JPY 102.9B 107M 2024-09
Merck USD 9.66B 1.67B 2025-03
Novartis USD 10.15B 579M 2024-12
Pfizer USD 18.17B 5.63B 2024-12
Sanofi EUR 6.77B 3.75B 2024-12
Supernus Pharmaceuticals USD 152.75M 17.91M 2024-12



Indivior 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2025.